ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
HM
Hertsen Moscow Oncology Research Institute at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Hertsen Moscow Oncology Research Institute takes part in 3 sessions at ESMO 2026 in Madrid. Its work spans genomic profiling and treatment of rare cancers. It describes an integrated approach to profiling solid tumors and real-world eribulin use in advanced liposarcoma.
| Organization | ESMO 2026 Attendance |
|---|---|
HM Hertsen Moscow Oncology Research Institute Moscow, Russian Federation | |
Oncology research and treatment institute in Moscow, Russian Federation. | Poster Fri Oct 23 13:00–15:00 ARIADNA: An integrated platform for comprehensive genomic profiling in solid tumors Biomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Eribulin in patients with unresectable or metastatic liposarcoma after anthracycline-containing chemotherapy: A real-world retrospective cohort study Sarcoma, CNS, head & neck and rare cancers Poster Mon Oct 26 12:00–12:45 Pembrolizumab and lenvatinib in patients with advanced adrenocortical carcinoma: Preliminary results of non-randomized phase II study Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at Hertsen Moscow Oncology Research Institute
Tell us what you sell and we’ll find the people at Hertsen Moscow Oncology Research Institute most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction